| GLP | glucagon-like peptide; glucose-L-phosphate; glycolipoprotein; good laboratory practice; group living program |
|---|---|
| GLPR | glucagon-like peptide receptor |
| GLP | Glucagon-like peptide |
|---|---|
| GLP | Glycolipoprotein |
| GLP | Good Laboratory Practice |
| GLP-1 | 1.Glucagon-like peptide-1 amide |
| GLP-1 | Glucagon-Like Peptide-1 |
| GLP-1 | Glucagon-like peptide 1 (7-36)amide |
| GLP-1(7-36)amide | Glucagon like peptide-1(7-36) amide |
| GLP-2 | Glucagon-like peptide 2 |
| GLP-I | Glucagon-like peptide I |
| GLPD | granular lymphocyte proliferative disorder |
| Glp | A keto derivative of proline that is formed nonenzymatically from glutamate, glutamine, and gamma-glutamylated peptides; it is also produced by the action of gamma-glutamylcyclotransferase; elevated levels of 5-oxoproline are often associated with problems of glutamine or glutathione metabolism. Synonym: 5-pyrrolidone-2-carboxylic acid, pyroglutamic acid, pyrrolidone-5-carboxylate. (05 Mar 2000) |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|---|---|---|---|
|
±ÛÇǸ®µåÁ¤ - »õâ
|
ÇìÆÄ°¡µå |
A57000231 | Glimepiride | Àü¹®ÀǾàǰ | ±Þ¿© |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|